Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOTANIX PHARMACEUTICALS LTD Director's Dealing 2019

Dec 2, 2019

64551_rns_2019-12-02_43cecdf5-c538-4e0d-9bc9-0666d1fb0584.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Botanix Pharmaceuticals Limited ABN 70 009 109 755

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Robert Towner
Date of last notice 1 May 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest. •Austin 4 Pty Ltd ATF <R&S Towner Super A/C>•Austin 4 Pty Ltd Family Trust <R&S Towner Family A/C>_Relevant interests arise through shareholdings and directorships _
Date of change 2 December 2019
No. of securities held prior to change 749,986Ordinary Shares held by Austin 4 Pty Ltd ATF<R&STowner Super A/C>4,053,990 Unlisted Options, exercisable at $0.0675 expiring 1December 2019 and vesting progressively over three years ateach 30 November, subject to continued service to the Company,held by Austin 4 Pty Ltd <R&S Towner Family Account>
Class Ordinary SharesUnlisted Options
Number acquired 4,053,990 Ordinary Shares
Number disposed 4,053,990 Unlisted Options
Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation $0.0675 per Unlisted Options exercised
No. of securities held after change 749,986 Ordinary Shares held by Austin 4 Pty Ltd ATF<R&S
Towner Super A/C>
4,053,990 Ordinary Shares held by Austin 4 Pty Ltd <R&S
Towner Family Account>
Nature of change Exercise and expiry of Unlisted Options
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

thispart.
Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above No
traded during a+closed period where prior written clearance
was required?
If so, was prior written clearance provided to allow the trade to N/A
proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?